346 related articles for article (PubMed ID: 34267374)
1. Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch.
Dai L; Xu K; Li J; Huang Q; Song J; Han Y; Zheng T; Gao P; Lu X; Yang H; Liu K; Xia Q; Wang Q; Chai Y; Qi J; Yan J; Gao GF
Nat Immunol; 2021 Aug; 22(8):958-968. PubMed ID: 34267374
[TBL] [Abstract][Full Text] [Related]
2. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
Front Immunol; 2018; 9():597. PubMed ID: 29740424
[TBL] [Abstract][Full Text] [Related]
4. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
5. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
6. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
[TBL] [Abstract][Full Text] [Related]
7. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?
Gunawardana SA; Shaw RH
BMC Infect Dis; 2018 Dec; 18(1):641. PubMed ID: 30526531
[TBL] [Abstract][Full Text] [Related]
9. Dimerization of Dengue Virus E Subunits Impacts Antibody Function and Domain Focus.
Thomas A; Thiono DJ; Kudlacek ST; Forsberg J; Premkumar L; Tian S; Kuhlman B; de Silva AM; Metz SW
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611757
[TBL] [Abstract][Full Text] [Related]
10. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
[TBL] [Abstract][Full Text] [Related]
11. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection.
Slon-Campos JL; Dejnirattisai W; Jagger BW; López-Camacho C; Wongwiwat W; Durnell LA; Winkler ES; Chen RE; Reyes-Sandoval A; Rey FA; Diamond MS; Mongkolsapaya J; Screaton GR
Nat Immunol; 2019 Oct; 20(10):1291-1298. PubMed ID: 31477918
[TBL] [Abstract][Full Text] [Related]
12. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
[TBL] [Abstract][Full Text] [Related]
13. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
Uno N; Ross TM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
[TBL] [Abstract][Full Text] [Related]
14. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
15. A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses.
Wollner CJ; Richner M; Hassert MA; Pinto AK; Brien JD; Richner JM
J Virol; 2021 May; 95(12):. PubMed ID: 33762420
[TBL] [Abstract][Full Text] [Related]
16. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
[TBL] [Abstract][Full Text] [Related]
17. Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.
Brown JA; Singh G; Acklin JA; Lee S; Duehr JE; Chokola AN; Frere JJ; Hoffman KW; Foster GA; Krysztof D; Cadagan R; Jacobs AR; Stramer SL; Krammer F; García-Sastre A; Lim JK
Immunity; 2019 Mar; 50(3):751-762.e5. PubMed ID: 30737148
[TBL] [Abstract][Full Text] [Related]
18. Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.
Li A; Xue M; Attia Z; Yu J; Lu M; Shan C; Liang X; Gao TZ; Shi PY; Peeples ME; Boyaka PN; Liu SL; Li J
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554698
[TBL] [Abstract][Full Text] [Related]
19. Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
Zimmerman MG; Quicke KM; O'Neal JT; Arora N; Machiah D; Priyamvada L; Kauffman RC; Register E; Adekunle O; Swieboda D; Johnson EL; Cordes S; Haddad L; Chakraborty R; Coyne CB; Wrammert J; Suthar MS
Cell Host Microbe; 2018 Nov; 24(5):731-742.e6. PubMed ID: 30439342
[TBL] [Abstract][Full Text] [Related]
20. Human antibody response to Zika targets type-specific quaternary structure epitopes.
Collins MH; Tu HA; Gimblet-Ochieng C; Liou GA; Jadi RS; Metz SW; Thomas A; McElvany BD; Davidson E; Doranz BJ; Reyes Y; Bowman NM; Becker-Dreps S; Bucardo F; Lazear HM; Diehl SA; de Silva AM
JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]